Cognition Therapeutics, Inc. (CGTX) Insider Trading
Over the last 3 months, CGTX insiders made 3 open-market buys and 0 sales, a net purchase of $32K (SEC Form 4). Multiple insiders bought within days of each other (cluster buying). Over the last 6 months, 39 institutions increased and 32 reduced their position (13F).
Insider Activity
Sentiment
100/100
Buys (3m)
3
Sells (3m)
0
Net (3m)
$32.5K
Insiders buyingCluster buying
Insider trades by month Buys Sells
Oct
Nov
Mar
Feb
Apr
Context3-month price +51.4%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 22, 2026 | Fletcher Aaron G.L.director, 10 percent owner: | Grant | 25,000 | — |
| Jun 22, 2026 | Khattar Jack A.director | Grant | 25,000 | — |
| Jun 22, 2026 | Monia Brett Pdirector | Grant | 25,000 | — |
| Jun 22, 2026 | Wallace Peggydirector | Grant | 25,000 | — |
| Jun 22, 2026 | RICHSTONE ELLEN Bdirector | Grant | 25,000 | — |
| May 4, 2026 | Doyle John Brendanofficer: Chief Financial Officer | Tax | 8,567 | $1.28 |
| Apr 20, 2026 | Caggiano Anthonyofficer: Chief Medical Officer | Buy | 10,000 | $1.11 |
| Apr 20, 2026 | Doyle John Brendanofficer: Chief Financial Officer | Buy | 10,000 | $1.13 |
| Apr 20, 2026 | Ricciardi Lisadirector, officer: CEO & President | Buy | 9,175 | $1.10 |
| Feb 18, 2026 | Doyle John Brendanofficer: Chief Financial Officer | Tax | 1,560 | $1.12 |
| Feb 18, 2026 | Caggiano Anthonyofficer: Chief Medical Officer | Tax | 4,680 | $1.12 |
| Feb 18, 2026 | Ricciardi Lisadirector, officer: CEO & President | Tax | 5,850 | $1.12 |
| Feb 5, 2026 | Doyle John Brendanofficer: Chief Financial Officer | Tax | 26,921 | $1.03 |
| Feb 5, 2026 | Ricciardi Lisadirector, officer: CEO & President | Grant | 800,000 | — |
| Feb 5, 2026 | Ricciardi Lisadirector, officer: CEO & President | Tax | 26,036 | $1.12 |
| Feb 5, 2026 | Ricciardi Lisadirector, officer: CEO & President | Tax | 51,704 | $1.03 |
| Feb 5, 2026 | Doyle John Brendanofficer: Chief Financial Officer | Grant | 200,000 | — |
| Feb 5, 2026 | Caggiano Anthonyofficer: Chief Medical Officer | Grant | 400,000 | — |
| Feb 5, 2026 | Caggiano Anthonyofficer: Chief Medical Officer | Tax | 26,919 | $1.03 |
| Feb 5, 2026 | Caggiano Anthonyofficer: Chief Medical Officer | Tax | 11,488 | $1.12 |
| Dec 22, 2025 | Doyle John Brendanofficer: Chief Financial Officer | Tax | 9,360 | $1.50 |
| Dec 22, 2025 | Ricciardi Lisadirector, officer: CEO & President | Grant | 75,000 | — |
| Dec 22, 2025 | Ricciardi Lisadirector, officer: CEO & President | Tax | 23,400 | $1.50 |
| Dec 22, 2025 | Caggiano Anthonyofficer: Chief Medical Officer | Grant | 65,000 | — |
| Dec 22, 2025 | Caggiano Anthonyofficer: Chief Medical Officer | Tax | 20,280 | $1.50 |
| Dec 22, 2025 | Doyle John Brendanofficer: Chief Financial Officer | Grant | 30,000 | — |
| Sep 23, 2025 | Fletcher Aaron G.L.director, 10 percent owner: | Option | 7,729 | $0.84 |
| Jul 31, 2025 | Ricciardi Lisadirector, officer: CEO & President | Tax | 23,400 | $0.67 |
| Jul 31, 2025 | Doyle John Brendanofficer: Chief Financial Officer | Grant | 30,000 | — |
| Jul 31, 2025 | Caggiano Anthonyofficer: Chief Medical Officer | Tax | 20,281 | $0.67 |
Source: CGTX SEC Form 4 filings, latest Jun 22, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their CGTX positions over the last 6 months (SEC Form 13F).
Increased
39
New positions
28
Reduced
32
Sold out
23
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 6.0M | May 15, 2026 |
| BIOS CAPITAL MANAGEMENT, LP | Unchanged | 6.0M | Feb 13, 2026 |
| BIOS CAPITAL MANAGEMENT, LP | Unchanged | 6.0M | May 13, 2026 |
| VANGUARD GROUP INC | Increased | 3.3M | Jan 29, 2026 |
| DAVENPORT & CO LLC | Increased | 2.9M | Apr 15, 2026 |
| DAVENPORT & CO LLC | Increased | 2.9M | Jan 12, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 1.1M | May 14, 2026 |
| BLACKROCK, INC. | Increased | 1.0M | Feb 12, 2026 |
| CHESCAPMANAGER LLC | Unchanged | 997K | May 14, 2026 |
| CHESCAPMANAGER LLC | Unchanged | 997K | Feb 13, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 970K | Feb 12, 2026 |
| BLACKROCK, INC. | Reduced | 968K | May 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 920K | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 874K | Feb 9, 2026 |
| JANE STREET GROUP, LLC | Reduced | 614K | Feb 12, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.